The Latest Breaking News from Goldman Sachs

Hawkish expectations in Asia’s emerging markets are piling up as traders become increasingly convinced that central banks in the region cannot ignore the threat of domestic inflation any longer.

Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00. Shares of GoodRx Holdings are trading up 1.32% over the last 24 hours, at $8.07 per share.

A whale with a lot of money to spend has taken a noticeably bearish stance on Goldman Sachs Group. Looking at options history for Goldman Sachs Group (NYSE:GS) we detected 21 strange trades.

Reuters US Trucking Downturn Threatens Autonomous Operators like Uber Freight

Goldman Sachs Group Inc (NYSE: GS) investors are suing the bank over the 1MDB scandal and are seeking sworn testimony from three former employees who live in the U.K.

The tumble shows what a market downdraft can do to speculative investments that don’t produce cash flows

RedBird Capital Partners - shareholders in Liverpool owners FSG - remain in the race to take over at Italian giants AC Milan

Republicans are mulling retaliation against firms providing benefits such as travel assistance for employees seeking abortion

U.S. regulatory officials arrived in Beijing seeking to settle a long-running dispute over the auditing compliance of U.S.-listed Chinese firms, Reuters reported, citing sources. The stand-off, if not resolved, could see Chinese firms kicked off New York bourses. This week the SEC added over 80 firms to the list of companies…

Some small businesses are still struggling to hire qualified workers, even as the broader picture in the U.S. job market looks much brighter

Someone with a lot of money to spend has taken a bearish stance on Goldman Sachs Group (NYSE:GS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.